Javier Botín
Beyond's analysis on Javier Botín
- — Sesderma founder publicly challenges Javier Botín over JB Capital's stake, promising documentation
- — Javier Botín’s purchase of half of Sesderma values the dermocosmetics group at €200 million and places JB Capital in control amid a debt‑restructuring that makes Kartesia the main creditor
- — Palacios bolsters its sandwich division with Javier Botín‑backed acquisition of Spain’s Ñaming brand